bims-sikglu Biomed News
on Salt inducible kinases in glucose metabolism
Issue of 2025–02–09
one paper selected by
Dipsikha Biswas, Københavns Universitet and Maria Madrazo i Montoya, Københavns Universitet



  1. Endocrinology. 2025 Feb 07. pii: bqaf024. [Epub ahead of print]
      Salt-inducible kinases (SIKs), a member of the serine/threonine protein kinase family, have recently garnered significant research interest as one of the emerging key regulators of metabolism. The three SIK isoforms-SIK1, SIK2, and SIK3-exhibit diverse roles in both central and peripheral physiological processes. While early studies focused on their role in inflammation, spurring the development of SIK inhibitors for chronic inflammatory diseases currently in clinical trials, emerging evidence highlights their broader functions in metabolism. In this review, we will summarise the current state of research on the central roles of SIKs in the brain, particularly in regulating energy balance and glucose homeostasis, alongside their peripheral functions in critical metabolic tissues such as the liver, adipose tissue, and pancreas. By integrating insights into their central and peripheral roles, this review underscores the significance of SIKs in maintaining metabolic homeostasis and highlights their therapeutic potential as novel targets for metabolic disease.
    Keywords:  Salt-inducible kinases; energy balance; glucose homeostasis; metabolic disease; metabolism
    DOI:  https://doi.org/10.1210/endocr/bqaf024